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Abstract
Introduction
More than 30 million adults are released from incarceration globally each year. Many experience complex physical and mental health problems,
and are at markedly increased risk of preventable mortality. Despite this, evidence regarding the global epidemiology of mortality following
release from incarceration is insufficient to inform the development of targeted, evidence-based responses. Many previous studies have suffered
from inadequate power and poor precision, and even large studies have limited capacity to disaggregate data by specific causes of death,
sub-populations or time since release to answer questions of clinical and public health relevance.
Objectives
To comprehensively document the incidence, timing, causes and risk factors for mortality in adults released from prison.
Methods
We created the Mortality After Release from Incarceration Consortium (MARIC), a multi-disciplinary collaboration representing 29 cohorts of
adults who have experienced incarceration from 11 countries. Findings across cohorts will be analysed using a two-step, individual participant
data meta-analysis methodology.
Results
The combined sample includes 1,337,993 individuals (89% male), with 75,795 deaths recorded over 9,191,393 person-years of follow-up.
Conclusions
The consortium represents an important advancement in the field, bringing international attention to this problem. It will provide interna-
tionally relevant evidence to guide policymakers and clinicians in reducing preventable deaths in this marginalized population.
Key words
Mortality; incarceration; prison; release; individual participant data meta-analysis; consortium; cohort.
Introduction
Each year more than 30 million people are released from incarcer-
ation globally [1] and this figure is increasing at a rate in excess of
population growth [2,3]. The United States (US) imprisons more
people than any other country, accounting for more than one-fifth
of the estimated 11 million adults incarcerated worldwide on any
given day [3]. Due to the large incarcerated population and the
rapid turnover of people detained in jails [4], more than 12 million
adults cycle through US correctional facilities annually – more than
in any other country [5-7]. For many, release from incarceration
compounds pre-existing disadvantage as they experience challenges
securing stable accommodation and employment, accessing health
services, and reconnecting with families, social groups and commu-
nities [8]. Further, the risk of premature mortality for adults re-
leased from incarceration is substantially higher than in the general
population [9]. There are compelling, evidence-based arguments
for improving health outcomes and reducing mortality in this pop-
ulation based on human rights, public health, criminal justice, and
economic grounds [10,11].
There is an established literature documenting an elevated risk
of premature death in the first four weeks after release from in-
carceration [12-16]. However, the specificity of this increased risk
window - and beyond - has not been well characterized. Several bar-
riers have hampered research intended to inform efforts to reduce
mortality in this population. First, the absolute number of recorded
deaths in most cohorts is relatively small, and some causes of death
– such as Human Immunodeficiency Virus (HIV) – remain compar-
atively rarer in younger populations [17]. As a result, even studies
with large samples may lack sufficient statistical power to disaggre-
gate by specific sub-populations (e.g., younger women, men from
ethnic minorities), causes of death (e.g., deaths due to suicide, drug
overdose, violence, HIV), or windows of time (e.g., the first four
weeks after release from incarceration). Yet it is precisely this gran-
ularity that is required to meaningfully inform targeted prevention
efforts. Second, synthesising findings across published studies is dif-
ficult due to the statistical and conceptual heterogeneity observed
in published findings to date [9]. Third, researchers may not publish
negative findings, or those that were based on insufficient statistical
power, and this possible publication bias would threaten the inter-
nal validity of findings based exclusively on aggregating published
data only. Fourth, jurisdictional data-sharing restrictions have pre-
vented the generation of informative, international benchmarks for
mortality after incarceration, such as those produced by the Global
Burden of Disease study [18] for population-level morbidity and
mortality. Critical questions about the epidemiology of mortality in
this vulnerable population therefore remain unanswered.
Few attempts to date have been made to synthesise the litera-
ture examining mortality after release from incarceration. Kinner et
al. [9] conducted a systematic review of studies examining mortal-
ity after release from incarceration, with their review including 29
publications from 25 individual studies, mainly from high-income,
Western countries. They documented widely varying mortality esti-
mates, noting that common, avoidable, and significant methodolog-
ical limitations - and reducible heterogeneity - contributed heavily to
this variation. Kinner et al. [9] also identified important knowledge
gaps and recommended a targeted meta-analysis of the literature to
examine the extent to which the risk of death from specific causes
is elevated after release from incarceration, and whether this risk
is concentrated in the period immediately following release. Jones
et al. [19] conducted a meta-analysis of suicide deaths following
release from prison and their findings demonstrated that the risk of
suicide in adults following release was 6.8 times that of their non-
incarcerated peers (95% confidence intervals: 6.1–7.5). However,
their analyses were based on suicide deaths only and were restricted
to the five studies (out of nine) with sufficient published data to
be included in the meta-analysis. Merrall et al. [12] conducted
a meta-analysis of studies examining drug-related deaths follow-
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ing prison release and reported an acute elevation in drug-related
deaths in the first two weeks post-release. However, their analyses
(a) were restricted to a single cause of death; (b) included only six
studies that published their findings in a way that permitted meta-
analysis; (c) were restricted to two-week intervals up to 12 weeks
post-release, due to power limitations; and (d) did not disaggregate
findings by specific sub-populations, limiting the generalisability of
the findings. Zlodre et al. [20] conducted a systematic review and
meta-analysis of all-cause mortality following release from prison,
reporting standardized mortality ratios of 1.0 - 9.4 for males and 2.6
- 41.3 for females, compared to their non-incarcerated peers. The
authors included 16 studies from three countries in their analysis,
but noted that important gaps remained, such as disaggregation of
mortality rates by age, ethnicity, and time since release.
To address the knowledge gaps identified above, we have cre-
ated the international Mortality After Release from Incarceration
Consortium (MARIC). This aim of this paper is to describe the
composition of the Consortium, its data, objectives and research
methodology.
Consortium description
The Consortium is an international, multi-disciplinary and multi-
organisational collaboration of researchers, clinicians and policy-
makers and represents the largest coordinated effort to date world-
wide to examine mortality in adults who have experienced incar-
ceration. The Consortium is led by the University of Melbourne in
Australia and is funded by Australia’s National Health and Medi-
cal Research Council (NHMRC; grant #1120004). It is an open
Consortium and welcomes new collaboration proposals from aca-
demics, policymakers, clinicians, and service providers worldwide.
The Consortium’s current dataset is comprised of 29 cohorts of
adults who have experienced incarceration from 11 countries: Aus-
tralia, Canada, French Guiana (France), Indonesia, Malaysia, the
Netherlands, Norway, Scotland, Sweden, Taiwan, and the USA (see
Supplementary Figure 1). It combines data regarding individuals
who have served (or are serving) a custodial sentence and data re-
garding individuals who are have been (or are) incarcerated whilst
awaiting trial or sentencing. Importantly, the Consortium has ac-
cess to both published and unpublished data from these cohorts (see
Table 1 for descriptive information about each study). Seventeen
studies are retrospective cohort studies and twelve are prospective
cohort studies (see Appendix 1 for further information about each
study’s sampling frame, follow-up time and objectives).
All data have been collected between 1980 and 2017 (see Fig-
ure 1) and all studies received ethics approval from relevant local
authorities and committees. The total combined sample size of
the Consortium is 1,337,993 formerly incarcerated adults, includ-
ing 153,062 (11%) women. A total of 75,795 deaths have been
recorded over 9,191,393 089 person-years of follow-up, and future
data linkage updates planned by several cohorts will further expand
these totals in the future.
Raw data across the individual cohorts are highly comparable,
with many similar measures recorded. Table 2 displays the key
variables recorded by each of the 29 cohorts in the Consortium,
and how they were measured. All cohort datasets contain data
relating to sex, age, date of release from custody, and date and
cause(s) of death. Most cohort datasets (25/29; 86%) contain
a measure of ethnicity or race. All cohorts use national (n=17),
state-based (n=9), or municipal (n=4) death indices (or a combi-
nation of these) to ascertain cohort mortality. Causes of death are
categorised using the International Classification of Diseases (ICD)
[38] codes in all cohorts. Twenty cohorts (69%) contain infor-
mation regarding dates of all incarceration (and re-incarceration)
episodes. Additionally, 16 cohorts (55%) contain information re-
garding previous substance use problems or treatment (including
during incarceration), and nine cohorts contain information regard-
ing previous mental health problems or treatment (including during
incarceration).
Individual cohort predictor and outcome data have been col-
lected over a period of 37 years, permitting the detection of changes
in mortality trends and determinants over calendar time follow-
ing release from prison. The data obtained create a large com-
bined sample of individuals with a proportionally large number of
person-years of follow-up time, both of which are orders of mag-
nitude greater than that available from any previous study. Ac-
cordingly, the Consortium has sufficient statistical power to a)
examine specific (including rare) causes of death, and b) con-
duct meta-regression analyses to consider findings according to
key demographic, policy-based and country-level variables, eluci-
dating country-specific structural factors contributing to the ob-
served heterogeneity in mortality estimates. Finally, due to the
multi-disciplinary nature of the Consortium, interpretation of find-
ings will also benefit from expert knowledge and experience across
a wide spectrum of health and criminal justice settings.
Outcomes
The main outcome of the Consortium is mortality after release from
incarceration. The aims of the Consortium are to: 1) comprehen-
sively establish the incidence and timing of all-cause and cause-
specific mortality in adults following release from incarceration in-
ternationally; 2) identify risk factors for all-cause and cause-specific
mortality following release from incarceration; and 3) examine how
risk differs across settings, time, and specific sub-populations. The
specific causes of mortality we will examine are:
1. Non-communicable diseases (e.g., asthma [ICD-10: J45-
J46], chronic obstructive pulmonary disease [ICD-10: J40-
J44; J47], diabetes [ICD-10: E10-E14], cardiovascular dis-
ease [ICD-10: I60-I69], cancer [ICD-10 Chapter II]);
2. Alcohol and other drug-related (e.g., opioid overdoses [ICD-
10: T40.0-T40.6], alcohol-related deaths [ICD-10: F10], pre-
scribed medications [T43]);
3. Suicide (e.g., self-inflicted injuries [X60-X84]);
4. Infectious diseases (e.g., HIV [ICD-10: B20-B24], hepatitis
C [ICD-10: B17], tuberculosis [ICD-10: A15-A19]); and
5. Injuries other than self-inflicted injuries and poisoning (e.g.,
firearm homicide [ICD-10: X93-X95], assault by bodily force
[ICD-10: Y04], legal intervention [ICD-10: Y35-Y36], road
traffic accidents [ICD-10: V01]).
Data Analysis
Data analysis for the Consortium is structured around the aims
outlined above and will involve a series of two-step, individual par-
ticipant data meta-analyses (IPDM-A) [39](see Figure 2). In the
first stage of the analysis, individual-level data from each cohort’s
dataset will be analysed locally by approved analysts in each cohort
team according to a pre-specified statistical analysis plan. This plan
will define the inclusion and exclusion criteria, specify how data will
be harmonised prior to analysis, specify all variables included in the
analysis and - for categorical variables - the omitted variables for
dummy coding, the specific analytic method (e.g., survival anal-
ysis), and how the effect sizes will be presented (e.g., as hazard
ratios with standard errors). In the second stage, the results of
these analyses will be transferred to a single location (the Univer-
sity of Melbourne) for pooling using random-effects meta-analysis.
Again, this will be pre-specified so that only the exposures of in-
terest are examined (with all other predictors considered as con-
founding factors). All releases from incarceration will be included
3
Borschmann, R et. al. / International Journal of Population Data Science (2019) 5:1:06
Figure 1: Sampling and follow-up time by cohort for the 29 cohorts in the Mortality After Release from Incarceration Consortium
(MARIC).
in future analysis plans, such that one individual can contribute
data from multiple incarcerations and releases. To account for
multiple releases from incarceration, we will use person-time in the
community (follow-up time minus the duration of any periods of
re-incarceration) as the denominator when calculating crude and
multivariate incidence rates. There are methodological, statistical
and clinical advantages to using two-step IPDM-A compared to the
traditional meta-analytic approach [39] (see Supplementary Box 1),
and this approach has been successfully applied to studies of coro-
nary heart disease [40], vascular mortality [41], and HIV treatment
[42] – but not to mortality in adults released from incarceration.
With MARIC data stored and governed by data custodians across
11 countries, and ethical and cross-jurisdictional data-sharing re-
strictions preventing the direct sharing of individual-level data [43],
the two-step IPDM-A methodology overcomes these barriers and
permits data analysis across all data sources in the Consortium.
To account for participant overlap between cohorts – for exam-
ple, there is a small degree of overlap between the Rosen [34] and
Ranapurwala [44] cohorts from the US, and also some overlap be-
tween the Dolan [24], Degenhardt [22] and Karaminia [29] cohorts
from Australia – we will ensure that all participants, person-time
and deaths are only included once prior to conducting any data
analysis.
Strengths and Weaknesses
Strengths of our consortium include its large sample size, its multi-
national composition, and its use of ICD codes to assign causes
of death. Our Consortium has some limitations. First, 25 of
the 29 cohorts (86%) come from high-income countries, with a
geographical distribution concentrated in North America (n=12),
Australia (n=8), and Western Europe (n=4). While this also rep-
resents an advantage, due to the broad similarities of the crim-
inal justice systems in these regions, further data on the health
of people who experience incarceration in low- and middle-income
countries are urgently needed [45]. To this end, researchers from
such under-researched settings are encouraged to join the Consor-
tium and a) contribute extant data, or b) develop new datasets to
address this limitation. Second, consistent with international incar-
ceration rates [46], men make up a large proportion (88%) of the
combined MARIC sample. However, the Consortium provides an
unprecedented opportunity to examine mortality in a large sample
of women (N=153,062) released from incarceration across eight
countries. Third, the Consortium includes cohorts with a degree
of heterogeneity and this is likely to have impacted the observed
mortality estimates. For example, participants in several cohorts all
have as inclusion criteria a history of opioid dependence [22, 24, 47]
and/or a diagnosis of HIV [28, 47, 48], contributing to an increased
risk of mortality. The impact of this cohort heterogeneity will be
explored by conducting sensitivity analyses which exclude selected
cohorts.
Conclusion and future research
The disproportionate rates of premature mortality experienced by
adults released from incarceration [9] represents an unnecessary and
preventable loss of life. The MARIC study is the largest coordi-
nated effort worldwide to rigorously and comprehensively examine
mortality in a population who often experience profound disadvan-
tage, complex physical and mental health problems, in addition to
an increased risk of preventable mortality.
Importantly, incarceration itself is a high-risk event for morbidity
and mortality outcomes [49, 50] and international efforts focussing
on diverting vulnerable people away from incarceration are war-
ranted to reduce the high rates of incarceration currently observed
worldwide [3]. Simultaneously, incarcerated people at increased risk
of mortality following release must be identified prior to release so
that appropriate evidence-based interventions can be implemented
in a timely manner. Identifying people who are disproportionately
likely to experience challenges relating to accommodation, food
security, employment, and substance use following release from in-
carceration will also likely identify those at an increased risk of
premature mortality. Another possible avenue is the development
and implementation of clinical prediction rules to identify those at
highest risk of mortality following release from incarceration, com-
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Figure 2: Two-step, individual participant data meta-analysis (IPDM-A) methodology.
parable to Fazel and colleagues’ prediction rule to identify people
at highest risk of violent recidivism after prison release [51]. Similar
rules for mortality, if they could be developed, would potentially be
inexpensive and scalable, and findings could be used to link people
identified as being at increased risk with appropriate treatment and
care during the incarceration period, and ongoing care after release.
The MARIC Consortium represents an opportunity to substan-
tially improve the evidence base regarding mortality in adults re-
leased from incarceration and produce targeted, globally relevant
evidence on the epidemiology of mortality in this population. The
overarching aim of the Consortium is to substantially increase the
accuracy, precision, clinical relevance and translational impact of
research on mortality in adults following release from incarceration
across countries. Findings and recommendations from the Con-
sortium will lay the foundation for policy reform, targeted clinical
intervention, and rigorous evaluation of scalable interventions that
have the potential to reduce the unnecessary wastage of lives after
release from incarceration internationally.
How can I find out more or get in-
volved?




cific inquiries, including collaboration proposals, can be directed
to the Consortium’s Chief Investigator, Dr. Rohan Borschmann
(rohan.borschmann@unimelb.edu.au). The Mortality After Re-
lease from Incarceration Consortium includes all authors listed
above, in addition to Trudi Cooper, Neil Drew, Lisa Duffy, Michael
Farrell, Cath Ferguson, Natalie Gately, Natasa Gisev, Ann-Claire
Larsen, Jo Kimber, Richard Mattick, Paul Nieuwbeerta, Moira Sim,
Di Twigg, and Jacqui Whale.
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